Compare Radiant Utama Interinsco Tbk. (RUIS) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Radiant Utama Interinsco Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Radiant Utama Interinsco Tbk. trades at Rp212 (market cap 160.16B, 5.69M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Radiant Utama Interinsco Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| RUIS | SCPI | |
|---|---|---|
Market Cap | 160.16B | 104.4B |
Volume | 5.69M | — |
Lot | 56.9K | — |
Turnover | 1.23B | — |
Average Price | 216.05 | — |
Value | 1.23B | — |
Indicative Equilibrium Price | 212 | — |
Indicative Equilibrium Volume | 694 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Radiant Utama Interinsco Tbk.
PT Radiant Utama Interinsco (Company) was established base on notarial deed No.41 of Mr Hadi Moentoro, dated August 22, 1984. The deed of establishment was approved by the Ministry of Justice in its decision letter No. C2-574-HT.01.01.Th.85 dated Feb 11, 1985.The Company’s articles of association has been amended several times, most recently by notarial deed No. 28 of Mr. P. Soetrisno A. Tampubolon, S.H., dated Dec 19, 2005, concerning among others, the increasing paid up capital, increase authorized share, and change in the Company’s par value.PT Radiant Utama Interinsco (Company) was established base on notarial deed No.41 of Mr Hadi Moentoro, dated August 22, 1984. The deed of establishment was approved by the Ministry of Justice in its decision letter No. C2-574-HT.01.01.Th.85 dated Feb 11, 1985.The Company’s articles of association has been amended several times, most recently by notarial deed No. 28 of Mr. P. Soetrisno A. Tampubolon, S.H., dated Dec 19, 2005, concerning among others, the increasing paid up capital, increase authorized share, and change in the Company’s par value.
Read more on RUIS →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
